HIKMA PHARMACEUTICALS PLC 25/04/2022 AGM
1Receive the Annual ReportAbstain
2Approve the DividendFor
3Re-appoint PricewaterhouseCoopers LLP as AuditorsOppose
4Authorise the Audit Committee to Fix Remuneration of AuditorsFor
5Re-elect Said Darwazah - Chair (Executive)Oppose
6Re-elect Sigurdur ‘Siggi Olafsson - Chief ExecutiveFor
7Re-elect Mazen Darwazah - Vice Chair (Executive)Oppose
8Re-elect Patrick Butler - Senior Independent DirectorFor
9Elect Ali Al-Husry - Non-Executive DirectorFor
10Elect John Castellani - Non-Executive DirectorOppose
11Re-elect Nina Henderson - Designated Non-ExecutiveFor
12Re-elect Cynthia Flowers - Non-Executive DirectorAbstain
13Re-elect Douglas Hurt - Non-Executive DirectorFor
14Approve the Remuneration ReportOppose
15Approve the Conversion of the Merger Reserve to a Distributable ReserveFor
16Issue Shares with Pre-emption RightsAbstain
17Issue Shares for CashFor
18Issue Shares for Cash for the Purpose of Financing an Acquisition or Other Capital InvestmentOppose
19Authorise Share RepurchaseOppose
20Meeting Notification-related ProposalFor